Active Watch List: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), Delta Air Lines, Inc. (NYSE:DAL), Hallmark Financial Services Inc. (NASDAQ:HALL), Cesca Therapeutics Inc. (NASDAQ:KOOL)

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) belongs to Healthcare sector. Its weekly performance is -7.77%. On last trading day company shares ended up $10.80. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) distance from 50-day simple moving average (SMA50) is -4.35%.On 1 July, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) announced that its partner, Santen Pharmaceutical Co. Ltd. (Santen), filed an Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) for the initiation of clinical studies for DE-122 in patients with wet AMD. DE-122 is the ophthalmic formulation of TRACON’s proprietary anti-endoglin antibody, TRC105. In March 2014, Santen licensed the global rights for the development of TRC105 in ophthalmology from Tracon.

Delta Air Lines, Inc. (NYSE:DAL) shares advanced 4.71% in last trading session and ended the day at $42.46. DAL Gross Margin is 41.60% and its return on assets is 2.20%. Delta Air Lines, Inc. (NYSE:DAL) quarterly performance is -1.58%. Delta Air Lines, Inc. (NYSE:DAL) said that, it will increase service offered between New York’s John F. Kennedy International Airport and premier West Coast destinations Los Angeles and San Francisco, Beginning in November 2015

On 10 July, Hallmark Financial Services Inc. (NASDAQ:HALL) shares advanced 0.53% and was closed at $11.42. HALL EPS growth in last 5 year was -10.30%. Hallmark Financial Services Inc. (NASDAQ:HALL) year to date (YTD) performance is -5.54%.On 7 July, Hallmark Financial Services Inc. (NASDAQ:HALL) said that, it will close its 1-million-square-foot Enfield distribution center and eliminate 570 jobs over the next year, ending 63 years of operation in the town.

Cesca Therapeutics Inc. (NASDAQ:KOOL) ended the last trading day at $0.71. Company weekly volatility is calculated as 9.04% and price to cash ratio as 6.00. Cesca Therapeutics Inc. (NASDAQ:KOOL) showed a weekly performance of -13.50%. Cesca Therapeutics Inc. (NASDAQ:KOOL)‘s stock had its “neutral” rating restated by stock analysts at HC Wainright in a report issued on Wednesday.

Leave a Reply

Your email address will not be published. Required fields are marked *